FULC Fulcrum Therapeutics, Inc.
Healthcare · Market cap: $287.6M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $3.5M |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $13.7M | $0 |
| 2023-Q1 | $26.3M | $101.5K |
| 2023-Q2 | $0 | $695 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $492.1K | $57.2K |
| 2024-Q2 | $0 | $1.8K |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $2.5K |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $58.6M |
| 2026-Q1 | $0 | $501.9K |
| 2026-Q2 | $0 | $65.7K |
| 2026-Q3 | $1.5M | $0 |
| 2026-Q4 | $0 | $0 |
Bought$42.0M13 buy days
Sold$62.8M19 sell days
Net insider flow-$20.9Mnet selling · 5 years
Latest trade2026-07-17TANG KEVIN
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-07-17 | Buy | TANG KEVIN | 10% owner | 50,945 | $3.52 | $179.3K | 1 |
| 2026-07-16 | Buy | TANG KEVIN | 10% owner | 116,671 | $3.56 | $415.3K | 1 |
| 2026-07-15 | Buy | TANG KEVIN | 10% owner | 107,377 | $3.56 | $382.3K | 1 |
| 2026-07-14 | Buy | TANG KEVIN | 10% owner | 129,603 | $3.57 | $462.9K | 2 |
| 2026-07-13 | Buy | TANG KEVIN | 10% owner | 12,966 | $3.54 | $45.9K | 1 |
| 2026-06-26 | Sell | Ezekowitz Alan | Director | 18,000 | $3.65 | $65.7K | 1 |
| 2026-02-02 | Sell | Gould Robert J | Director | 15,000 | $10.72 | $160.8K | 1 |
| 2026-01-02 | Sell | Gould Robert J | Director | 30,000 | $11.37 | $341.1K | 2 |
| 2025-12-15 | Sell | Oltmans Curtis Gale | Other C-suite | 3,452 | $12.92 | $44.6K | 1 |
| 2025-12-08 | Sell | RA Capital Healthcare Fund LP | 10% owner | 4,175,139 | $13.98 | $58.4M | 3 |
| 2025-11-19 | Sell | Gould Robert J | Director | 15,000 | $11.03 | $165.4K | 1 |
| 2025-05-08 | Sell | Tourangeau Greg | Other officer | 498 | $5.06 | $2.5K | 1 |
| 2024-05-07 | Sell | Tourangeau Greg | Other officer | 236 | $7.76 | $1.8K | 1 |
| 2024-03-08 | Sell | Tourangeau Greg | VP | 4,884 | $11.72 | $57.2K | 1 |
| 2024-03-04 | Buy | Sapir Alex | Director | 43,360 | $11.35 | $492.1K | 1 |
| 2023-05-10 | Sell | Tourangeau Greg | Other officer | 210 | $3.31 | $695 | 1 |
| 2023-01-20 | Buy | RA Capital Healthcare Fund LP | 10% owner | 1,923,076 | $13.00 | $25.0M | 1 |
| 2023-01-13 | Sell | Gould Robert J | CEO | 6,766 | $15.00 | $101.5K | 1 |
| 2023-01-04 | Buy | RA Capital Healthcare Fund LP | 10% owner | 180,703 | $7.28 | $1.3M | 2 |
| 2022-12-27 | Buy | RA Capital Healthcare Fund LP | 10% owner | 4,089 | $5.99 | $24.5K | 1 |
| 2022-12-19 | Buy | RA Capital Healthcare Fund LP | 10% owner | 98,787 | $5.90 | $582.8K | 1 |
| 2022-12-16 | Buy | RA Capital Healthcare Fund LP | 10% owner | 1,341,420 | $5.42 | $7.3M | 1 |
| 2022-12-15 | Buy | RA Capital Healthcare Fund LP | 10% owner | 237,029 | $5.50 | $1.3M | 1 |
| 2022-12-14 | Buy | RA Capital Healthcare Fund LP | 10% owner | 824,600 | $5.46 | $4.5M | 1 |
| 2022-06-07 | Sell | Gould Robert J | Director | 71,435 | $8.09 | $577.9K | 1 |
| 2022-06-06 | Sell | Gould Robert J | Director | 24,382 | $8.10 | $197.5K | 1 |
| 2022-06-03 | Sell | Gould Robert J | Director | 25,551 | $7.95 | $203.1K | 1 |
| 2022-06-02 | Sell | Gould Robert J | Director | 16,689 | $7.92 | $132.2K | 1 |
| 2022-04-07 | Sell | Gould Robert J | Director | 5,631 | $24.02 | $135.3K | 1 |
| 2022-04-05 | Sell | Gould Robert J | Director | 52,552 | $24.26 | $1.3M | 1 |
| 2022-04-04 | Sell | Gould Robert J | Director | 7,235 | $24.02 | $173.8K | 1 |
| 2022-04-01 | Sell | Gould Robert J | Director | 34,464 | $24.03 | $828.2K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| RA Capital Healthcare Fund LP | 10% owner | $40.0M | $58.4M | 2025-12-08 |
| Gould Robert J | Director | $0 | $4.3M | 2026-02-02 |
| TANG KEVIN | 10% owner | $1.5M | $0 | 2026-07-17 |
| Sapir Alex | Director | $492.1K | $0 | 2024-03-04 |
| Ezekowitz Alan | Director | $0 | $65.7K | 2026-06-26 |
| Tourangeau Greg | Other officer | $0 | $62.3K | 2025-05-08 |
| Oltmans Curtis Gale | Other C-suite | $0 | $44.6K | 2025-12-15 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2021-06-28 | 4 | $132.2K | 43 | -23.2% (-26.5% raw) | +182.4% (+179.3% raw) | +69.4% (+67.5% raw) | closed |
| 2019-07-22 | 6 | $9.5M | 51 | -9.9% (-12.1% raw) | -55.5% (-54.8% raw) | +20.5% (+31.5% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.